<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02568995</url>
  </required_header>
  <id_info>
    <org_study_id>THA2014</org_study_id>
    <nct_id>NCT02568995</nct_id>
  </id_info>
  <brief_title>Pain Management Following Total Hip Arthroplasty</brief_title>
  <acronym>FEMORALIA</acronym>
  <official_title>Postoperative Pain Management Following Total Hip Arthroplasty. A Comparison Between Local Infiltration Analgesia and Ultrasound Guided 3-in-1 Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Örebro University, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Örebro University, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total hip arthroplasty (THA) is a common and standardized procedure. Postoperative mortality&#xD;
      after hip joint replacement is low but some complications remain, including chronic&#xD;
      post-surgical pain (1), hip dislocation (2), infection (3), and deep vein thrombosis (4).&#xD;
      Strategies that have been identified to reduce morbidity and mortality include: posterior&#xD;
      surgical approach, mechanical and pharmacological prophylaxis of deep vein thrombosis, and&#xD;
      the use of spinal anesthesia (5). One of the important factors for patient satisfaction with&#xD;
      lower limb arthroplasty is good postoperative pain management (6). Poorly managed&#xD;
      postoperative pain can lead to chronic post-surgical pain and therefore aggressive&#xD;
      postoperative pain management is important (7). Several different methods have been used to&#xD;
      treat postoperative pain following THA. Recently, local infiltration analgesia (LIA) using a&#xD;
      combination of large volume local anesthetics (LA) and non-steroidal anti-inflammatory agents&#xD;
      (NSAID) injected systematically peri-articularly has been used for pain management with&#xD;
      variable success (8). We found that better analgesia could be achieved when using LIA&#xD;
      compared to intrathecal morphine during the first few days postoperatively (9,10).&#xD;
&#xD;
      Ultrasound techniques are commonly used for peripheral nerve blocks and have been shown to&#xD;
      reduce pain intensity and may be considered by many to be a standard of care. Specifically,&#xD;
      the 3-in-1 block has been commonly used because of its ease of application and good pain&#xD;
      management following total hip arthroplasty. The present study aims to compare postoperative&#xD;
      pain intensity following local infiltration analgesia with a standardised 3-in-1 block for&#xD;
      total hip arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty ASA I-II patients undergoing THA would be randomised to one of two groups in a&#xD;
      double-blind study:&#xD;
&#xD;
      Group LIA: A total of 151.5 ml of a combination of 0.2% ropivacaine (150 ml), 30 mg ketorolac&#xD;
      (1 ml) and 0.5 mg (0.5 ml) adrenaline was administered systematically peri-articularly during&#xD;
      THA and 30 ml of normal saline for ultrasound-guided 3-in-1 block Group Femoral block:&#xD;
      Received 30 ml of ropivacaine 0,75% for ultrasound-guided 3-in-1 block and a total of 151.5&#xD;
      ml of normal saline peri-articularly.&#xD;
&#xD;
      All patients would receive spinal anaesthesia with 0.5% heavy bupivacaine for surgery&#xD;
&#xD;
      Postoperatively, the following parameters would be measured:&#xD;
&#xD;
        1. Pain intensity at fixed time intervals during 0-7 days and thereafter at weekly&#xD;
           intervals for 1 month&#xD;
&#xD;
        2. Rescue morphine consumption during 0-4, 4-24 and 24-48 h&#xD;
&#xD;
        3. Side effects and complications&#xD;
&#xD;
        4. Home readiness and length of hospital stay&#xD;
&#xD;
        5. Chronic pain intensity measured after 3 and 6 months using the Brief Pain Inventory&#xD;
&#xD;
        6. Plasma Cytokine concentration at fixed intervals&#xD;
&#xD;
        7. Motor block using Bromage scale&#xD;
&#xD;
        8. EQ5D and HOOS questionnaires&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>24 h</time_frame>
    <description>Pain intensity during movement at 24 h after end of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rescue analgesic consumption</measure>
    <time_frame>0-24 h</time_frame>
    <description>Amount of PCA morphine used for pain management</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic pain</measure>
    <time_frame>3-6 months</time_frame>
    <description>Pain at 3 and 6 months after surgery using Brief Pain Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>Preoperative to 3-5 days postoperatively</time_frame>
    <description>Pre- and post-operative cytokine concentration would be measured</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Postoperative Pain Intensity</condition>
  <condition>Rescue Pain Requirements</condition>
  <arm_group>
    <arm_group_label>LIA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local infiltration analgesia using a combination of ropivacaine 300 mg + ketorolac 30 mg + adrenaline 0.5 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided 3-in-1 block using 30 ml of 0.75% ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine + ketorolac + adrenaline</intervention_name>
    <description>A combination of drugs injected locally for postoperative pain management</description>
    <arm_group_label>Femoral nerve block</arm_group_label>
    <arm_group_label>LIA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  40-80 years&#xD;
&#xD;
          -  ASA I-II&#xD;
&#xD;
          -  THA operation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic pain requiring opiates&#xD;
&#xD;
          -  Language constraints preventing completion of the study&#xD;
&#xD;
          -  Contraindications to regional block&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Karolinskasjukhuset</name>
      <address>
        <city>Solna</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Örebro</city>
        <zip>701 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>October 2, 2015</study_first_submitted>
  <study_first_submitted_qc>October 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2015</study_first_posted>
  <last_update_submitted>September 25, 2016</last_update_submitted>
  <last_update_submitted_qc>September 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Örebro University, Sweden</investigator_affiliation>
    <investigator_full_name>Anil Gupta</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>postoperative pain</keyword>
  <keyword>morphine</keyword>
  <keyword>total hip arthroplasty</keyword>
  <keyword>femoral nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

